Metabolic Syndrome Clinical Trial
— KREBSome-IRCOfficial title:
Contribution of Plasma Assays of Biomarkers of Muscle Metabolism During Exercise to the Assessment of Insulin Resistance in Chronic Renal Failure Patients Undergoing Hemodialysis.
This prospective, multicenter, cross-sectional, repeated-measures comparative study compared functional and biochemical response profiles to exercise between 2 groups of chronically ill patients (chronic renal failure dialysis patients and patients with metabolic syndrome) and a group of healthy subjects. The hypothesis is that the addition of plasma metabolic intermediates associated with energy disorders linked to insulin resistance, will improve the sensitivity of the assessment of muscle oxidative metabolism abnormalities, as reported in exercise intolerant subjects. In this way, the metabolomics approach during exercise would provide a biological and functional "signature" of insulin resistance of muscular origin, discriminating between insulin-resistant patients, healthy control subjects and dialysis patients, with an exercise metabolic profile approaching that observed in insulin-resistant patients. A better understanding of metabolic abnormalities could guide muscle rehabilitation. Participants will be asked to perform an exercise test, with several blood samples taken at different exercise intensities. Researchers will compare the metabolic profile of three groups: patients with chronic kidney disease, patients with metabolic syndrome and healthy subjects: - V'O2-adjusted lactate at rest and during exercise - The combination of exercise energy metabolism intermediates reflecting insulin resistance among Krebs cycle cofactors/substrates, ß-oxidation cofactors/substrates, amino acids
Status | Not yet recruiting |
Enrollment | 42 |
Est. completion date | May 1, 2026 |
Est. primary completion date | May 1, 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years to 75 Years |
Eligibility | Inclusion Criteria: Group 1: Healthy subjects: - Postmenopausal women aged 40 to 75 or men aged 40 to 75 - No chronic disease or treatment - BMI <30 kg/m², or - Fasting blood glucose < 1.10 g/dL Group 2: metabolic syndrome patients - Postmenopausal women aged 40 to 75 or men aged 40 to 75 - Metabolic syndrome as defined by the International Diabetes Federation (IDF 2006)5 - BMI <30 kg/m² and waist circumference >80 cm for women and >94 cm for men - Insulin resistance defined by HOMA-IR>2.4 Group 3: CKD dialysis patients - Non-diabetics - Postmenopausal women aged 40 to 75 and men aged 40 to 75 - BMI <30 kg/m². - Chronic kidney disease patients on dialysis - stable on HD for more than 3 months Patients and healthy subjects will be matched on age (+/-3 years) and sex Exclusion Criteria: - Non-stabilized pathology incompatible with physical exercise - Ongoing exercise retraining program - Nutritional supplementation in the 4 weeks preceding the study (antioxidants, vitamins, etc.) - Treatment influencing mitochondrial function (metformin, statin, etc.) - Failure to obtain written informed consent after a period of reflection - Subject not affiliated to a social security scheme, or not benefiting from such a scheme. - Person protected by law (under guardianship or curatorship) - Patient deprived of liberty - Diabetic patient - Family dyslipidemia - Participants who have reached the maximum amount of compensation for their participation in research projects - Person under psychiatric care - Person participating in another research project with an exclusion period still in progress. - Mentally handicapped, dementia, illiterate, language barrier with inability to understand study purpose and methodology |
Country | Name | City | State |
---|---|---|---|
France | AIDER Santé Fondation Charles Mion Montpellier, site Lapeyronie | Montpellier | |
France | Montpellier University Hospital | Montpellier |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compare V'O2-adjusted plasma lactate profile at rest and during exercise (metabolic stress test), between chronic renal failure patients, patients with metabolic syndrome and healthy subjects. | Measurements will be taken every 6 minutes, at rest and during exercise on a cycloergometer, corresponding to intensities of 0% (rest) 20%, 30%, 40%, 50 and 60% of the subject's estimated maximum power.
The gas exchange measurement (V'O2 and V'CO2 (milliliter per minute mL/min)) will be carried out cycle-by-cycle using a gas analyzer connected to a flow meter. The intensity corresponding to the rate of maximum lipid oxidation will be defined as LIPOXMAX, and will be expressed in Watts (W), and as a % of theoretical VO2max. Carbohydrate (G) and lipid (L) oxidation rates will be calculated as follows: G (mg/min) = 4.585 VCO2 - 3.2255 VO2 L (mg/min) = 1.6946 VO2 - 1.7012 VCO2 Blood sampling at various levels on a peripheral venous catheter synchronized with stress test measurements. A comparison will be made on the basis of an analysis of variance by ANOVA one way after verification of the conditions of application or a rank test by analysis via Kruskal-Wallis. |
Baseline (rest), 6, 12, 18, 24, 30 minutes | |
Secondary | Compare between the 3 groups their metabolic profile (Krebs cycle cofactors/substrates) adjusted to V'O2 at rest and during exercise. | "Metabolic" Exercice test on a cycloergometer with gas measurement and peripheral venous sampling at various intensities.
HOMA-IR score (Homeostatic model assessment of insulin resistance) is calculated using simultaneous measurement of insulin and plasma glucose levels, a score above 2.4 is diagnostic of insulin resistance. A combination of exercise energy metabolism intermediates based on candidate metabolites with a significant correlation coefficient >0.7 compared to LIPOXmax and/or HOMA-IR, from among the following Krebs cycle cofactors/substrates : lactate, pyruvate, malate, citrate, succinate, fumarate and alpha-cetoglutarate Correlations will be characterized by Pearson's correlation test (correlation considered significant for coefficients >0.7). Logistic regression analysis will be used to characterize insulin resistance in the different groups on the basis of the data collected. |
Baseline (rest), 6, 12, 18, 24, 30 minutes | |
Secondary | Compare between the 3 groups their metabolic profile (ß-oxidation cofactors/substrates) adjusted to V'O2 at rest and during exercise. | "Metabolic" Exercise test on a cycloergometer with gas measurement and peripheral venous sampling at various intensities.
HOMA-IR score (Homeostatic model assessment of insulin resistance) is calculated using simultaneous measurement of insulin and plasma glucose levels, a score above 2.4 is diagnostic of insulin resistance. A combination of exercise energy metabolism intermediates based on candidate metabolites with a significant correlation coefficient >0.7 compared to LIPOXmax and/or HOMA-IR, from among the following ß-oxidation cofactors/substrates : free fatty acids, acyl-carnitine profile, beta-hydroxybutyrate, acetoacetate Correlations will be characterized by Pearson's correlation test (correlation considered significant for coefficients >0.7). Logistic regression analysis will be used to characterize insulin resistance in the different groups on the basis of the data collected. |
Baseline (rest), 6, 12, 18, 24, 30 minutes | |
Secondary | Compare between the 3 groups their metabolic profile (amino acids) adjusted to V'O2 at rest and during exercise. | "Metabolic" Exercise test on a cycloergometer with gas measurement and peripheral venous sampling at various intensities.
HOMA-IR score (Homeostatic model assessment of insulin resistance) is calculated using simultaneous measurement of insulin and plasma glucose levels, a score above 2.4 is diagnostic of insulin resistance. A combination of exercise energy metabolism intermediates based on candidate metabolites with a significant correlation coefficient >0.7 compared to LIPOXmax and/or HOMA-IR, from among the following amino acids. Correlations will be characterized by Pearson's correlation test (correlation considered significant for coefficients >0.7). Logistic regression analysis will be used to characterize insulin resistance in the different groups on the basis of the data collected. |
Baseline (rest), 6, 12, 18, 24, 30 minutes | |
Secondary | Compare between the 3 groups their metabolic profile (acyl-carnitine profiles) adjusted to V'O2 at rest and during exercise. | "Metabolic" Exercise test on a cycloergometer with gas measurement and peripheral venous sampling at various intensities.
HOMA-IR score (Homeostatic model assessment of insulin resistance) is calculated using simultaneous measurement of insulin and plasma glucose levels, a score above 2.4 is diagnostic of insulin resistance. A combination of exercise energy metabolism intermediates based on candidate metabolites with a significant correlation coefficient >0.7 compared to LIPOXmax and/or HOMA-IR, from among the following acyl-carnitine profiles Correlations will be characterized by Pearson's correlation test (correlation considered significant for coefficients >0.7). Logistic regression analysis will be used to characterize insulin resistance in the different groups on the basis of the data collected. |
Baseline (rest), 6, 12, 18, 24, 30 minutes | |
Secondary | Anthropometry Comparison between the 3 groups | calculation of BMI with the Measurement of weight (in kilograms Kg) and height (in centimetres cm). | Baseline (rest) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04635202 -
Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome
|
N/A | |
Completed |
NCT04053686 -
An Intervention to Reduce Prolonged Sitting in Police Staff
|
N/A | |
Completed |
NCT05343858 -
Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Recruiting |
NCT05040958 -
Carotid Atherosclerotic Plaque Load and Neck Circumference
|
||
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Completed |
NCT03289897 -
Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
Active, not recruiting |
NCT03613740 -
Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
|
Phase 2 | |
Completed |
NCT04498455 -
Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
|
Phase 4 | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03697382 -
Effect of Daily Steps on Fat Metabolism
|
N/A | |
Completed |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
Completed |
NCT04509206 -
Virtual Teaching Kitchen
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A |